[{"start_date": "2025-07-01", "end_date": "2025-09-30", "filing_date": "2025-11-12", "acceptance_datetime": "2025-11-12T21:16:06Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2025", "cik": "0001583107", "sic": "2834", "tickers": ["TBPH"], "company_name": "Theravance Biopharma, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001104659-25-110382", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001104659-25-110382/files/tbph-20250930x10q_htm.xml", "financials": {"income_statement": {"income_loss_from_continuing_operations_before_tax": {"value": -2889000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "benefits_costs_expenses": {"value": 22879000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_available_to_common_stockholders_basic": {"value": 3615000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "basic_earnings_per_share": {"value": 0.07, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "operating_income_loss": {"value": -6455000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_after_tax": {"value": 3615000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "selling_general_and_administrative_expenses": {"value": 18333000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "basic_average_shares": {"value": 50520000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss_attributable_to_parent": {"value": 3615000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "costs_and_expenses": {"value": 22879000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "revenues": {"value": 19990000.0, "unit": "USD", "label": "Revenues", "order": 100}, "diluted_earnings_per_share": {"value": 0.07, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "income_tax_expense_benefit": {"value": -6504000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss": {"value": 3615000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "research_and_development": {"value": 8112000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "diluted_average_shares": {"value": 51908000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "operating_expenses": {"value": 26445000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": 3657000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 3657000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": 3657000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "balance_sheet": {"liabilities": {"value": 182779000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "accounts_payable": {"value": 2213000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "wages": {"value": 10330000.0, "unit": "USD", "label": "Wages", "order": 730}, "assets": {"value": 415460000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_current_liabilities": {"value": 24864000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_assets": {"value": 60763000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities_and_equity": {"value": 415460000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_noncurrent_assets": {"value": 54506000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_liabilities": {"value": 37407000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity": {"value": 232681000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_liabilities": {"value": 145372000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_assets": {"value": 354697000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_parent": {"value": 232681000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "fixed_assets": {"value": 6257000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}}}}, {"start_date": "2025-04-01", "end_date": "2025-07-01", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2025", "cik": "0001583107", "sic": "2834", "tickers": ["TBPH"], "company_name": "Theravance Biopharma, Inc.", "financials": {"balance_sheet": {"equity": {"value": 224848000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities": {"value": -224848000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_parent": {"value": 224848000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": -224848000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}}}}, {"start_date": "2025-01-01", "end_date": "2025-03-31", "filing_date": "2025-05-12", "acceptance_datetime": "2025-05-12T20:29:21Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2025", "cik": "0001583107", "sic": "2834", "tickers": ["TBPH"], "company_name": "Theravance Biopharma, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-25-007398", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-25-007398/files/tbph-20250331x10q_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": 30632000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": 72817000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities": {"value": 30632000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": 43039000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": 43039000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": -854000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_financing_activities_continuing": {"value": -854000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": 72817000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -13586000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -13586000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -13586000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "income_statement": {"basic_earnings_per_share": {"value": -0.27, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_loss_from_continuing_operations_before_tax": {"value": -14138000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss": {"value": -13579000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_tax_expense_benefit": {"value": -559000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "costs_and_expenses": {"value": 29526000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "selling_general_and_administrative_expenses": {"value": 18370000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "diluted_earnings_per_share": {"value": -0.27, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "operating_expenses": {"value": 29822000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "basic_average_shares": {"value": 49706000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "benefits_costs_expenses": {"value": 29526000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_income_loss": {"value": -14434000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "diluted_average_shares": {"value": 49706000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_attributable_to_parent": {"value": -13579000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_after_tax": {"value": -13579000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "research_and_development": {"value": 11452000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_tax_expense_benefit_deferred": {"value": -1852000.0, "unit": "USD", "label": "Income Tax Expense/Benefit, Deferred", "order": 2400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -13579000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "revenues": {"value": 15388000.0, "unit": "USD", "label": "Revenues", "order": 100}}, "balance_sheet": {"equity_attributable_to_parent": {"value": 165983000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_current_liabilities": {"value": 23708000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity": {"value": 165983000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities_and_equity": {"value": 343582000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "liabilities": {"value": 177599000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_liabilities": {"value": 31502000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_assets": {"value": 150264000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "accounts_payable": {"value": 2408000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_noncurrent_assets": {"value": 186290000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "wages": {"value": 5386000.0, "unit": "USD", "label": "Wages", "order": 730}, "noncurrent_liabilities": {"value": 146097000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "fixed_assets": {"value": 7028000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "assets": {"value": 343582000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_assets": {"value": 193318000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}}}}, {"start_date": "2024-10-01", "end_date": "2024-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2024", "cik": "0001583107", "sic": "2834", "tickers": ["TBPH"], "company_name": "Theravance Biopharma, Inc.", "financials": {"cash_flow_statement": {"net_cash_flow_continuing": {"value": 14419000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -902000, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities": {"value": -365000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": -902000, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities_continuing": {"value": -365000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": 15686000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": 15686000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow": {"value": 14419000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}, "balance_sheet": {"accounts_payable": {"value": 2242000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "current_assets": {"value": 161067000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities": {"value": 178616000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "wages": {"value": 7019000.0, "unit": "USD", "label": "Wages", "order": 730}, "current_liabilities": {"value": 32085000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_parent": {"value": 175545000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_noncurrent_assets": {"value": 185676000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "fixed_assets": {"value": 7418000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_current_liabilities": {"value": 22824000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_liabilities": {"value": 146531000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities_and_equity": {"value": 354161000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity": {"value": 175545000.0, "unit": "USD", "label": "Equity", "order": 1400}, "assets": {"value": 354161000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_assets": {"value": 193094000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}}, "income_statement": {"operating_expenses": {"value": 27954000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_tax_expense_benefit_deferred": {"value": -6589000.0, "unit": "USD", "label": "Income Tax Expense/Benefit, Deferred", "order": 2400}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "selling_general_and_administrative_expenses": {"value": 18501000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "net_income_loss": {"value": -15527000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_loss_from_continuing_operations_after_tax": {"value": -15527000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "diluted_average_shares": {"value": 157000, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "basic_average_shares": {"value": 157000, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_tax_expense_benefit": {"value": 6588000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "diluted_earnings_per_share": {"value": -0.31, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "basic_earnings_per_share": {"value": -0.31, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "revenues": {"value": 18754000.0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_before_tax": {"value": 18754000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -15527000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "research_and_development": {"value": 9453000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "other_operating_expenses": {"value": 0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "operating_income_loss": {"value": -9200000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "costs_and_expenses": {"value": 27954000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_attributable_to_parent": {"value": -15527000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -15527000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -15527000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}}}, {"start_date": "2024-07-01", "end_date": "2024-09-30", "filing_date": "2024-11-14", "acceptance_datetime": "2024-11-14T11:06:02Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2024", "cik": "0001583107", "sic": "2834", "tickers": ["TBPH"], "company_name": "Theravance Biopharma, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-24-015602", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-24-015602/files/tbph-20240930x10q_htm.xml", "financials": {"balance_sheet": {"noncurrent_liabilities": {"value": 147016000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities_and_equity": {"value": 356105000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "liabilities": {"value": 170451000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "accounts_payable": {"value": 1454000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "current_assets": {"value": 116480000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_current_liabilities": {"value": 14139000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "assets": {"value": 356105000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_noncurrent_assets": {"value": 231837000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_liabilities": {"value": 23435000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "fixed_assets": {"value": 7788000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "wages": {"value": 7842000.0, "unit": "USD", "label": "Wages", "order": 730}, "equity_attributable_to_parent": {"value": 185654000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_assets": {"value": 239625000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity": {"value": 185654000.0, "unit": "USD", "label": "Equity", "order": 1400}}, "income_statement": {"diluted_earnings_per_share": {"value": -0.26, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "operating_expenses": {"value": 27705000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_available_to_common_stockholders_basic": {"value": -12698000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_tax_expense_benefit": {"value": 2646000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "diluted_average_shares": {"value": 49038000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "income_loss_from_continuing_operations_after_tax": {"value": -12698000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "basic_average_shares": {"value": 49038000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "income_loss_from_continuing_operations_before_tax": {"value": -10052000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "costs_and_expenses": {"value": 27705000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "research_and_development": {"value": 9268000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_parent": {"value": -12698000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "other_operating_expenses": {"value": 1562000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "basic_earnings_per_share": {"value": -0.26, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss": {"value": -12698000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_income_loss": {"value": -10837000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "selling_general_and_administrative_expenses": {"value": 16875000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "income_tax_expense_benefit_deferred": {"value": 90000, "unit": "USD", "label": "Income Tax Expense/Benefit, Deferred", "order": 2400}, "revenues": {"value": 16868000.0, "unit": "USD", "label": "Revenues", "order": 100}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -12698000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -12626000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": -17399000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities": {"value": -372000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities_continuing": {"value": -17399000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow": {"value": -22967000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -5196000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -5196000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": -22967000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": -372000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}}}}, {"start_date": "2024-04-01", "end_date": "2024-06-30", "filing_date": "2024-08-08", "acceptance_datetime": "2024-08-08T20:57:24Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2024", "cik": "0001583107", "sic": "2834", "tickers": ["TBPH"], "company_name": "Theravance Biopharma, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-24-011636", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-24-011636/files/tbph-20240630x10q_htm.xml", "financials": {"balance_sheet": {"current_liabilities": {"value": 22946000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities_and_equity": {"value": 362029000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_current_liabilities": {"value": 15498000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_parent": {"value": 193689000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "assets": {"value": 362029000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_assets": {"value": 119307000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity": {"value": 193689000.0, "unit": "USD", "label": "Equity", "order": 1400}, "other_noncurrent_assets": {"value": 234580000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "accounts_payable": {"value": 1674000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "fixed_assets": {"value": 8142000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "wages": {"value": 5774000.0, "unit": "USD", "label": "Wages", "order": 730}, "liabilities": {"value": -193689000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_assets": {"value": 242722000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}}, "income_statement": {"diluted_average_shares": {"value": 48747000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_attributable_to_parent": {"value": -16529000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "basic_average_shares": {"value": 48747000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_available_to_common_stockholders_basic": {"value": -16529000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "selling_general_and_administrative_expenses": {"value": 17056000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_expenses": {"value": 29961000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "operating_income_loss": {"value": -15705000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss": {"value": -16529000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "research_and_development": {"value": 9954000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_tax_expense_benefit_deferred": {"value": -561000, "unit": "USD", "label": "Income Tax Expense/Benefit, Deferred", "order": 2400}, "revenues": {"value": 14256000.0, "unit": "USD", "label": "Revenues", "order": 100}, "income_tax_expense_benefit": {"value": 1308000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "diluted_earnings_per_share": {"value": -0.34, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "costs_and_expenses": {"value": 29961000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "basic_earnings_per_share": {"value": -0.34, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_loss_from_continuing_operations_after_tax": {"value": -16529000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "income_loss_from_continuing_operations_before_tax": {"value": -15221000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "other_operating_expenses": {"value": 2951000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}}, "cash_flow_statement": {"net_cash_flow": {"value": -7490000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -4415000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": -7490000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": -3031000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": -3031000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -4415000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities": {"value": -44000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_financing_activities_continuing": {"value": -44000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -16510000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -16529000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}}}, {"start_date": "2024-01-01", "end_date": "2024-03-31", "filing_date": "2024-05-15", "acceptance_datetime": "2024-05-15T10:26:01Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2024", "cik": "0001583107", "sic": "2834", "tickers": ["TBPH"], "company_name": "Theravance Biopharma, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-24-008201", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-24-008201/files/tbph-20240331x10q_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": -1716000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities_continuing": {"value": 17028000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": 17028000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -1022000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": 14290000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -1022000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": -1716000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": 14290000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -11640000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -11664000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "income_statement": {"operating_expenses": {"value": 25710000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_after_tax": {"value": -11664000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "other_operating_expenses": {"value": 0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "diluted_average_shares": {"value": 48283000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_available_to_common_stockholders_basic": {"value": -11664000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "interest_expense_operating": {"value": 629000, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "diluted_earnings_per_share": {"value": -0.24, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_attributable_to_parent": {"value": -11664000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss": {"value": -11664000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "revenues": {"value": 14503000.0, "unit": "USD", "label": "Revenues", "order": 100}, "income_tax_expense_benefit_deferred": {"value": -513000, "unit": "USD", "label": "Income Tax Expense/Benefit, Deferred", "order": 2400}, "basic_average_shares": {"value": 48283000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "income_tax_expense_benefit": {"value": 1262000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "costs_and_expenses": {"value": 25710000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "selling_general_and_administrative_expenses": {"value": 16742000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "research_and_development": {"value": 8968000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "operating_income_loss": {"value": -11207000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "basic_earnings_per_share": {"value": -0.24, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_loss_from_continuing_operations_before_tax": {"value": -10402000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}}, "balance_sheet": {"current_assets": {"value": 124294000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_assets": {"value": 247013000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_liabilities": {"value": 21662000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities": {"value": -204868000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_parent": {"value": 204868000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_current_liabilities": {"value": 15501000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "fixed_assets": {"value": 8717000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "assets": {"value": 371307000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities_and_equity": {"value": 371307000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "accounts_payable": {"value": 1686000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_noncurrent_assets": {"value": 238296000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity": {"value": 204868000.0, "unit": "USD", "label": "Equity", "order": 1400}, "wages": {"value": 4475000.0, "unit": "USD", "label": "Wages", "order": 730}}}}, {"start_date": "2023-10-01", "end_date": "2023-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2023", "cik": "0001583107", "sic": "2834", "tickers": ["TBPH"], "company_name": "Theravance Biopharma, Inc.", "financials": {"comprehensive_income": {"comprehensive_income_loss": {"value": -8510000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -8510000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "balance_sheet": {"equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_assets": {"value": 248458000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_parent": {"value": 212995000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "long_term_debt": {"value": 0, "unit": "USD", "label": "Long-term Debt", "order": 810}, "current_assets": {"value": 133541000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "wages": {"value": 6443000.0, "unit": "USD", "label": "Wages", "order": 730}, "accounts_payable": {"value": 1524000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "current_liabilities": {"value": 24767000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "fixed_assets": {"value": 9068000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity": {"value": 212995000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities_and_equity": {"value": 381999000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "liabilities": {"value": 169004000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_liabilities": {"value": 144237000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_current_liabilities": {"value": 16800000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "assets": {"value": 381999000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_noncurrent_assets": {"value": 239390000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}}, "income_statement": {"diluted_earnings_per_share": {"value": -0.17, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -8510000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_income_loss": {"value": -6240000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "basic_average_shares": {"value": -1984000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss": {"value": -8510000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_loss_from_continuing_operations_before_tax": {"value": -8510000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "diluted_average_shares": {"value": -1984000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "revenues": {"value": 17565000.0, "unit": "USD", "label": "Revenues", "order": 100}, "interest_expense_operating": {"value": 623000, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "other_operating_expenses": {"value": 0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_tax_expense_benefit": {"value": 3494000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "operating_expenses": {"value": 23805000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "basic_earnings_per_share": {"value": -0.17, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "benefits_costs_expenses": {"value": 26075000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_attributable_to_parent": {"value": -8510000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "research_and_development": {"value": 8313000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_after_tax": {"value": -8510000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "costs_and_expenses": {"value": 26075000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "selling_general_and_administrative_expenses": {"value": 15492000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities": {"value": -854000, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": -30609000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": -32140000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -854000, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": -32140000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities": {"value": -677000, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": -677000, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": -30609000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}}}, {"start_date": "2023-07-01", "end_date": "2023-09-30", "filing_date": "2023-11-09", "acceptance_datetime": "2023-11-09T21:46:52Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2023", "cik": "0001583107", "sic": "2834", "tickers": ["TBPH"], "company_name": "Theravance Biopharma, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-23-018612", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-23-018612/files/tbph-20230930x10q_htm.xml", "financials": {"income_statement": {"research_and_development": {"value": 8311000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "diluted_earnings_per_share": {"value": -0.17, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "income_loss_from_continuing_operations_before_tax": {"value": -7583000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "income_tax_expense_benefit": {"value": 1367000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "diluted_average_shares": {"value": 52361000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "selling_general_and_administrative_expenses": {"value": 16142000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "other_operating_expenses": {"value": 0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss": {"value": -8950000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_loss_from_continuing_operations_after_tax": {"value": -8950000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "basic_average_shares": {"value": 52361000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss_available_to_common_stockholders_basic": {"value": -8950000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_income_loss": {"value": -8760000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "revenues": {"value": 15693000.0, "unit": "USD", "label": "Revenues", "order": 100}, "benefits_costs_expenses": {"value": 24643000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "operating_expenses": {"value": 24453000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "costs_and_expenses": {"value": 24643000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "interest_expense_operating": {"value": 609000, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "net_income_loss_attributable_to_parent": {"value": -8950000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "basic_earnings_per_share": {"value": -0.17, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": -21000, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow": {"value": -33911000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": -31404000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -2486000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -2486000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": -21000, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": -33911000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": -31404000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -8950000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -8889000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "balance_sheet": {"noncurrent_liabilities": {"value": 142092000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_liabilities": {"value": 25368000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "assets": {"value": 413590000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_noncurrent_assets": {"value": 242612000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "wages": {"value": 6578000.0, "unit": "USD", "label": "Wages", "order": 730}, "equity": {"value": 246130000.0, "unit": "USD", "label": "Equity", "order": 1400}, "accounts_payable": {"value": 2368000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "fixed_assets": {"value": 9288000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "noncurrent_assets": {"value": 251900000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": 246130000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_assets": {"value": 161690000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities_and_equity": {"value": 413590000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_current_liabilities": {"value": 16422000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities": {"value": 167460000.0, "unit": "USD", "label": "Liabilities", "order": 600}}}}, {"start_date": "2023-04-01", "end_date": "2023-06-30", "filing_date": "2023-08-09", "acceptance_datetime": "2023-08-09T10:16:53Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2023", "cik": "0001583107", "sic": "2834", "tickers": ["TBPH"], "company_name": "Theravance Biopharma, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-23-014070", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-23-014070/files/tbph-20230630x10q_htm.xml", "financials": {"income_statement": {"selling_general_and_administrative_expenses": {"value": 19278000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "other_operating_expenses": {"value": 1169000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "benefits_costs_expenses": {"value": 29394000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_attributable_to_parent": {"value": -15645000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_after_tax": {"value": -15645000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_before_tax": {"value": -14187000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "basic_average_shares": {"value": 56682000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "diluted_earnings_per_share": {"value": -0.28, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "operating_expenses": {"value": 29872000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "operating_income_loss": {"value": -16123000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "research_and_development": {"value": 9425000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "interest_expense_operating": {"value": 568000, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "revenues": {"value": 13749000.0, "unit": "USD", "label": "Revenues", "order": 100}, "basic_earnings_per_share": {"value": -0.28, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "costs_and_expenses": {"value": 29394000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "diluted_average_shares": {"value": 56682000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "income_tax_expense_benefit": {"value": 1458000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss": {"value": -15645000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -15645000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -15645000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -15982000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -12436000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": -80680000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": -82069000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": -82069000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": 11047000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": -80680000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": 11047000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -12436000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}, "balance_sheet": {"current_liabilities": {"value": 24546000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_current_liabilities": {"value": 17606000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "other_noncurrent_assets": {"value": 245074000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "noncurrent_assets": {"value": 254627000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities": {"value": -280161000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_parent": {"value": 280161000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "fixed_assets": {"value": 9553000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "assets": {"value": 446630000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_assets": {"value": 192003000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "accounts_payable": {"value": 1569000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "wages": {"value": 5371000.0, "unit": "USD", "label": "Wages", "order": 730}, "liabilities_and_equity": {"value": 446630000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity": {"value": 280161000.0, "unit": "USD", "label": "Equity", "order": 1400}}}}, {"start_date": "2023-01-01", "end_date": "2023-03-31", "filing_date": "2023-05-10", "acceptance_datetime": "2023-05-10T10:16:01Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2023", "cik": "0001583107", "sic": "2834", "tickers": ["TBPH"], "company_name": "Theravance Biopharma, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-23-008951", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-23-008951/files/tbph-20230331x10q_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -22022000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -22088000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "balance_sheet": {"other_noncurrent_assets": {"value": 265109000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity": {"value": 370559000.0, "unit": "USD", "label": "Equity", "order": 1400}, "assets": {"value": 538550000.0, "unit": "USD", "label": "Assets", "order": 100}, "wages": {"value": 5030000.0, "unit": "USD", "label": "Wages", "order": 730}, "other_current_liabilities": {"value": 18491000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities_and_equity": {"value": 538550000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_liabilities": {"value": 26184000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "fixed_assets": {"value": 12103000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "noncurrent_assets": {"value": 277212000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "accounts_payable": {"value": 2663000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities": {"value": -370559000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": 370559000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_assets": {"value": 261338000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -11221000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities": {"value": -43046000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": -56240000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": -110507000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": -43046000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow": {"value": -110507000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -11221000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities": {"value": -56240000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}, "income_statement": {"net_income_loss_available_to_common_stockholders_basic": {"value": -22088000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_before_tax": {"value": -22483000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "interest_expense_operating": {"value": 550000, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "selling_general_and_administrative_expenses": {"value": 19183000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "basic_average_shares": {"value": 62934000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss_attributable_to_parent": {"value": -22088000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "basic_earnings_per_share": {"value": -0.35, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_expenses": {"value": 35329000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "revenues": {"value": 10417000.0, "unit": "USD", "label": "Revenues", "order": 100}, "research_and_development": {"value": 14572000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "diluted_average_shares": {"value": 62934000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "operating_income_loss": {"value": -24912000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_tax_expense_benefit": {"value": -395000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "costs_and_expenses": {"value": 32505000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_loss_from_continuing_operations_after_tax": {"value": -22088000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "diluted_earnings_per_share": {"value": -0.35, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss": {"value": -22088000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "other_operating_expenses": {"value": 1574000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "benefits_costs_expenses": {"value": 32505000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}}}}, {"start_date": "2022-10-01", "end_date": "2022-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2022", "cik": "0001583107", "sic": "2834", "tickers": ["TBPH"], "company_name": "Theravance Biopharma, Inc.", "financials": {"income_statement": {"diluted_earnings_per_share": {"value": -0.15, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "diluted_average_shares": {"value": -2087000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "selling_general_and_administrative_expenses": {"value": 15968000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "costs_and_expenses": {"value": 28905000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "basic_average_shares": {"value": -2087000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "interest_expense_operating": {"value": 550000, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "net_income_loss_available_to_common_stockholders_basic": {"value": -10362000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_income_loss": {"value": -17432000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "benefits_costs_expenses": {"value": 28905000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "income_loss_from_continuing_operations_before_tax": {"value": -14256000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "income_loss_from_continuing_operations_after_tax": {"value": -14256000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "basic_earnings_per_share": {"value": -0.15, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "other_operating_expenses": {"value": 1411000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_tax_expense_benefit": {"value": -3000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss_attributable_to_parent": {"value": -10362000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "revenues": {"value": 14649000.0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_discontinued_operations_net_of_tax": {"value": 3894000.0, "unit": "USD", "label": "Income/Loss From Discontinued Operations Net Of Tax", "order": 1600}, "research_and_development": {"value": 14701000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss": {"value": -10362000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_expenses": {"value": 32081000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}}, "balance_sheet": {"liabilities": {"value": 165600000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "liabilities_and_equity": {"value": 607400000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "fixed_assets": {"value": 11875000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_current_liabilities": {"value": 16847000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "accounts_payable": {"value": 1554000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_assets": {"value": 253936000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_noncurrent_assets": {"value": 242061000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "assets": {"value": 607400000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_liabilities": {"value": 28715000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity": {"value": 441800000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_assets": {"value": 353464000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_parent": {"value": 441800000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "wages": {"value": 10314000.0, "unit": "USD", "label": "Wages", "order": 730}, "noncurrent_liabilities": {"value": 136885000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -10362000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -10362000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_discontinued": {"value": 0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Discontinued", "order": 900}, "net_cash_flow_from_operating_activities_continuing": {"value": 54913000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_discontinued": {"value": 0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Discontinued", "order": 600}, "net_cash_flow_continuing": {"value": 58602000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": -120366000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -124055000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": 39161000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_discontinued": {"value": -178968000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Discontinued", "order": 300}, "net_cash_flow_from_financing_activities_continuing": {"value": -35472000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": -35472000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": 39161000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_discontinued": {"value": -178968000.0, "unit": "USD", "label": "Net Cash Flow, Discontinued", "order": 1300}}}}, {"start_date": "2022-07-01", "end_date": "2022-09-30", "filing_date": "2022-11-09", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2022", "cik": "0001583107", "sic": "2834", "tickers": ["TBPH"], "company_name": "Theravance Biopharma, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-22-017048", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-22-017048/files/tbph-20220930x10q_htm.xml", "financials": {"balance_sheet": {"noncurrent_liabilities": {"value": 140786000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_current_liabilities": {"value": 129235000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "current_liabilities": {"value": 142132000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities": {"value": 282918000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_noncurrent_assets": {"value": 239894000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "assets": {"value": 763496000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity": {"value": 480578000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities_and_equity": {"value": 763496000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_assets": {"value": 251778000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "wages": {"value": 7560000.0, "unit": "USD", "label": "Wages", "order": 730}, "equity_attributable_to_parent": {"value": 480578000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "accounts_payable": {"value": 5337000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "current_assets": {"value": 511718000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "fixed_assets": {"value": 11884000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": -701837000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": -722026000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities_continuing": {"value": -19725000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": -738101000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -22137000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -16539000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities": {"value": 1075409000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow": {"value": 331246000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": 916631000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": 916555000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "income_statement": {"diluted_average_shares": {"value": 75515000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "research_and_development": {"value": 9867000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "costs_and_expenses": {"value": 22911000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "operating_income_loss": {"value": -9144000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "operating_expenses": {"value": 21595000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "other_operating_expenses": {"value": 509000, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_parent": {"value": 916631000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "interest_expense_operating": {"value": 1545000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "income_loss_from_continuing_operations_after_tax": {"value": -10460000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "revenues": {"value": 12451000.0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_before_tax": {"value": -16023000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "income_tax_expense_benefit": {"value": -507000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_discontinued_operations_net_of_tax": {"value": 927091000.0, "unit": "USD", "label": "Income/Loss From Discontinued Operations Net Of Tax", "order": 1600}, "basic_average_shares": {"value": 75515000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "benefits_costs_expenses": {"value": 22911000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "basic_earnings_per_share": {"value": 12.14, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss_available_to_common_stockholders_basic": {"value": 916631000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss": {"value": 916631000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "selling_general_and_administrative_expenses": {"value": 16277000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "diluted_earnings_per_share": {"value": 12.14, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}}}}, {"start_date": "2022-04-01", "end_date": "2022-06-30", "filing_date": "2022-08-08", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2022", "cik": "0001583107", "sic": "2834", "tickers": ["TBPH"], "company_name": "Theravance Biopharma, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-22-012666", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-22-012666/files/tbph-20220630x10q_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -8208000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -8191000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "income_statement": {"diluted_earnings_per_share": {"value": -0.11, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "basic_earnings_per_share": {"value": -0.11, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_discontinued_operations_net_of_tax": {"value": 18379000.0, "unit": "USD", "label": "Income/Loss From Discontinued Operations Net Of Tax", "order": 1600}, "income_loss_from_equity_method_investments": {"value": 28127000.0, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "revenues": {"value": 11050000.0, "unit": "USD", "label": "Revenues", "order": 100}, "interest_expense_operating": {"value": 11884000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "income_loss_from_continuing_operations_before_tax": {"value": -8196000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "selling_general_and_administrative_expenses": {"value": 16986000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "net_income_loss_attributable_to_parent": {"value": -8191000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_income_loss": {"value": -26879000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "operating_expenses": {"value": 37929000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "research_and_development": {"value": 15571000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss": {"value": -8191000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_loss_before_equity_method_investments": {"value": -36323000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "income_tax_expense_benefit": {"value": -5000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "diluted_average_shares": {"value": 76270000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "costs_and_expenses": {"value": 37620000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "basic_average_shares": {"value": 76270000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "benefits_costs_expenses": {"value": 37620000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "income_loss_from_continuing_operations_after_tax": {"value": -26570000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "other_operating_expenses": {"value": 5372000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_available_to_common_stockholders_basic": {"value": -8191000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}}, "balance_sheet": {"equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_assets": {"value": 154729000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "fixed_assets": {"value": 12531000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity": {"value": -349809000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities": {"value": 349809000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "liabilities_and_equity": {"value": 360761000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "accounts_payable": {"value": 3074000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "assets": {"value": 360761000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_assets": {"value": 206032000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_liabilities": {"value": 32624000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_current_liabilities": {"value": 22592000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity_attributable_to_parent": {"value": -349809000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_noncurrent_liabilities": {"value": 53250000.0, "unit": "USD", "label": "Other Non-current Liabilities", "order": 820}, "other_noncurrent_assets": {"value": 193501000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "long_term_debt": {"value": 624696000.0, "unit": "USD", "label": "Long-term Debt", "order": 810}, "wages": {"value": 6958000.0, "unit": "USD", "label": "Wages", "order": 730}}, "cash_flow_statement": {"net_cash_flow": {"value": -7075000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -14730000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities": {"value": 7515000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": 7515000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": 140000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_financing_activities_continuing": {"value": 140000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -14730000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": -7075000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}}}, {"start_date": "2022-01-01", "end_date": "2022-03-31", "filing_date": "2022-05-06", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2022", "cik": "0001583107", "sic": "2834", "tickers": ["TBPH"], "company_name": "Theravance Biopharma, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-22-007651", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-22-007651/files/tbph-20220331x10q_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": 31924000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -26069000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities": {"value": 31924000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -26069000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": 4407000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": -1448000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_financing_activities_continuing": {"value": -1448000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": 4407000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -25974000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -25946000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "income_statement": {"net_income_loss_attributable_to_parent": {"value": -25946000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "revenues": {"value": 13196000.0, "unit": "USD", "label": "Revenues", "order": 100}, "operating_income_loss": {"value": -38502000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "diluted_average_shares": {"value": 75247000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "costs_and_expenses": {"value": 54734000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "basic_earnings_per_share": {"value": -0.34, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_loss_from_continuing_operations_before_tax": {"value": -25422000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_expenses": {"value": 51698000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_tax_expense_benefit": {"value": 524000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "income_loss_before_equity_method_investments": {"value": -50532000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "other_operating_expenses": {"value": 9324000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "selling_general_and_administrative_expenses": {"value": 19121000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "benefits_costs_expenses": {"value": 54734000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "research_and_development": {"value": 23253000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_equity_method_investments": {"value": 25110000.0, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "diluted_earnings_per_share": {"value": -0.34, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "interest_expense_operating": {"value": 11655000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "income_loss_from_continuing_operations_after_tax": {"value": -41538000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss": {"value": -25946000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -25946000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "basic_average_shares": {"value": 75247000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "income_loss_from_discontinued_operations_net_of_tax": {"value": 15592000.0, "unit": "USD", "label": "Income/Loss From Discontinued Operations Net Of Tax", "order": 1600}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}}, "balance_sheet": {"noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_liabilities": {"value": 44201000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "accounts_payable": {"value": 1510000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity_attributable_to_parent": {"value": -351450000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity": {"value": -351450000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_noncurrent_liabilities": {"value": 41132000.0, "unit": "USD", "label": "Other Non-current Liabilities", "order": 820}, "other_noncurrent_assets": {"value": 137487000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "fixed_assets": {"value": 13236000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "wages": {"value": 9560000.0, "unit": "USD", "label": "Wages", "order": 730}, "liabilities_and_equity": {"value": 355359000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_assets": {"value": 204636000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_assets": {"value": 150723000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "long_term_debt": {"value": 621476000.0, "unit": "USD", "label": "Long-term Debt", "order": 810}, "other_current_liabilities": {"value": 33131000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities": {"value": 351450000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "assets": {"value": 355359000.0, "unit": "USD", "label": "Assets", "order": 100}}}}, {"start_date": "2021-10-01", "end_date": "2021-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2021", "cik": "0001583107", "sic": "2834", "tickers": ["TBPH"], "company_name": "Theravance Biopharma, Inc.", "financials": {"balance_sheet": {"equity": {"value": -338573000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "fixed_assets": {"value": 13657000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity_attributable_to_parent": {"value": -338573000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "long_term_debt": {"value": 616334000.0, "unit": "USD", "label": "Long-term Debt", "order": 810}, "liabilities": {"value": 713392000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_assets": {"value": 124949000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities_and_equity": {"value": 374819000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_liabilities": {"value": 58587000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_liabilities": {"value": 654805000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "accounts_payable": {"value": 3098000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "current_assets": {"value": 249870000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_noncurrent_liabilities": {"value": 38471000.0, "unit": "USD", "label": "Other Non-current Liabilities", "order": 820}, "wages": {"value": 12796000.0, "unit": "USD", "label": "Wages", "order": 730}, "assets": {"value": 374819000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_current_liabilities": {"value": 42693000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "other_noncurrent_assets": {"value": 111292000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}}, "income_statement": {"basic_average_shares": {"value": 1516000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "income_loss_from_continuing_operations_before_tax": {"value": 14946000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "selling_general_and_administrative_expenses": {"value": 21516000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "diluted_average_shares": {"value": 1516000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_attributable_to_parent": {"value": -32034000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "research_and_development": {"value": 31226000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "diluted_earnings_per_share": {"value": -0.43, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss": {"value": -32034000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_income_loss": {"value": -56167000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "operating_expenses": {"value": 71113000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_before_equity_method_investments": {"value": -67491000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "income_loss_from_continuing_operations_after_tax": {"value": -32034000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_available_to_common_stockholders_basic": {"value": -32034000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "basic_earnings_per_share": {"value": -0.43, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "other_operating_expenses": {"value": 18371000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_loss_from_equity_method_investments": {"value": 35306000.0, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "income_tax_expense_benefit": {"value": -151000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "revenues": {"value": 14946000.0, "unit": "USD", "label": "Revenues", "order": 100}, "costs_and_expenses": {"value": 71113000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "interest_expense_operating": {"value": 11662000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": 10824000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow": {"value": -31461000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -42434000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": -42434000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": 10824000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 149000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": -31461000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 149000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -32034000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -32034000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}}}, {"start_date": "2021-07-01", "end_date": "2021-09-30", "filing_date": "2021-11-08", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2021", "cik": "0001583107", "sic": "2834", "tickers": ["TBPH"], "company_name": "Theravance Biopharma, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-21-014907", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-21-014907/files/tbph-20210930x10q_htm.xml", "financials": {"income_statement": {"selling_general_and_administrative_expenses": {"value": 21299000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "operating_income_loss": {"value": -53615000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_before_equity_method_investments": {"value": -65523000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "costs_and_expenses": {"value": 66809000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_loss_from_continuing_operations_before_tax": {"value": -35315000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_parent": {"value": -35308000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "basic_average_shares": {"value": 73574000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "operating_expenses": {"value": 66809000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "research_and_development": {"value": 43739000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "diluted_earnings_per_share": {"value": -0.48, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "other_operating_expenses": {"value": 1771000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "basic_earnings_per_share": {"value": -0.48, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_loss_from_equity_method_investments": {"value": 30208000.0, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "income_loss_from_continuing_operations_after_tax": {"value": -35308000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "interest_expense_operating": {"value": 11742000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "net_income_loss_available_to_common_stockholders_basic": {"value": -35308000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss": {"value": -35308000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "revenues": {"value": 13194000.0, "unit": "USD", "label": "Revenues", "order": 100}, "diluted_average_shares": {"value": 73574000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_tax_expense_benefit": {"value": -7000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}}, "balance_sheet": {"noncurrent_assets": {"value": 105937000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "long_term_debt": {"value": 615867000.0, "unit": "USD", "label": "Long-term Debt", "order": 810}, "assets": {"value": 403109000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_current_liabilities": {"value": 48547000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_liabilities": {"value": 660619000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities_and_equity": {"value": 403109000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "fixed_assets": {"value": 16003000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "accounts_payable": {"value": 8900000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_noncurrent_liabilities": {"value": 44752000.0, "unit": "USD", "label": "Other Non-current Liabilities", "order": 820}, "other_noncurrent_assets": {"value": 89934000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity": {"value": -323592000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_assets": {"value": 297172000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": -323592000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "wages": {"value": 8635000.0, "unit": "USD", "label": "Wages", "order": 730}, "liabilities": {"value": 726701000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_liabilities": {"value": 66082000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -35308000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -35302000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": -2286000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": -83525000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities": {"value": -35793000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow": {"value": -83525000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -45446000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": -35793000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": -2286000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -45446000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}}}, {"start_date": "2021-04-01", "end_date": "2021-06-30", "filing_date": "2021-08-05", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2021", "cik": "0001583107", "sic": "2834", "tickers": ["TBPH"], "company_name": "Theravance Biopharma, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-21-010555", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-21-010555/files/tbph-20210630x10q_htm.xml", "financials": {"balance_sheet": {"liabilities": {"value": 300374000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity": {"value": -300374000.0, "unit": "USD", "label": "Equity", "order": 1400}, "wages": {"value": 14635000.0, "unit": "USD", "label": "Wages", "order": 730}, "fixed_assets": {"value": 16583000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_noncurrent_assets": {"value": 79488000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "accounts_payable": {"value": 10702000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "long_term_debt": {"value": 609509000.0, "unit": "USD", "label": "Long-term Debt", "order": 810}, "current_liabilities": {"value": 67127000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "assets": {"value": 429251000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities_and_equity": {"value": 429251000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_noncurrent_liabilities": {"value": 52989000.0, "unit": "USD", "label": "Other Non-current Liabilities", "order": 820}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_current_liabilities": {"value": 41790000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_assets": {"value": 96071000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_assets": {"value": 333180000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_parent": {"value": -300374000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -52405000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -52414000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities": {"value": -50113000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": 90938000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": 35766000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": 35766000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -50113000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 105285000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_financing_activities_continuing": {"value": 105285000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": 90938000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}, "income_statement": {"net_income_loss_attributable_to_parent": {"value": -52405000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_before_tax": {"value": -52625000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_expenses": {"value": 77024000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "costs_and_expenses": {"value": 77024000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "basic_earnings_per_share": {"value": -0.8, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "operating_income_loss": {"value": -64110000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_available_to_common_stockholders_basic": {"value": -52405000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "revenues": {"value": 12914000.0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_equity_method_investments": {"value": 21926000.0, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss": {"value": -52405000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_loss_from_continuing_operations_after_tax": {"value": -52405000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "selling_general_and_administrative_expenses": {"value": 25931000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "interest_expense_operating": {"value": 11612000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "income_tax_expense_benefit": {"value": -220000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "research_and_development": {"value": 51093000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_before_equity_method_investments": {"value": -74551000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "diluted_earnings_per_share": {"value": -0.8, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "basic_average_shares": {"value": 65669000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "diluted_average_shares": {"value": 65669000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}}}}, {"start_date": "2021-01-01", "end_date": "2021-03-31", "filing_date": "2021-05-06", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2021", "cik": "0001583107", "sic": "2834", "tickers": ["TBPH"], "company_name": "Theravance Biopharma, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001558370-21-006234", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001558370-21-006234/files/tbph-20210331x10q_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": 113697000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": 113697000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": 32544000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": -11288000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -69865000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities": {"value": -11288000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": 32544000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -69865000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -79679000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -79709000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "income_statement": {"research_and_development": {"value": 67599000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "revenues": {"value": 14257000.0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_available_to_common_stockholders_basic": {"value": -79679000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss": {"value": -79679000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "basic_average_shares": {"value": 64723000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "selling_general_and_administrative_expenses": {"value": 30550000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "diluted_earnings_per_share": {"value": -1.24, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "income_loss_from_continuing_operations_before_tax": {"value": -79452000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_parent": {"value": -79679000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_tax_expense_benefit": {"value": 200000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "income_loss_from_equity_method_investments": {"value": 16547000.0, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "operating_expenses": {"value": 98149000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_after_tax": {"value": -79679000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "diluted_average_shares": {"value": 64493000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "costs_and_expenses": {"value": 98149000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "operating_income_loss": {"value": -83892000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_before_equity_method_investments": {"value": -95999000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "interest_expense_operating": {"value": 11873000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "basic_earnings_per_share": {"value": -1.24, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}}, "balance_sheet": {"other_current_liabilities": {"value": 64034000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity_attributable_to_parent": {"value": -373218000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_assets": {"value": 82037000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities": {"value": 373218000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "long_term_debt": {"value": 614070000.0, "unit": "USD", "label": "Long-term Debt", "order": 810}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_noncurrent_assets": {"value": 65093000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "assets": {"value": 375108000.0, "unit": "USD", "label": "Assets", "order": 100}, "fixed_assets": {"value": 16944000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "liabilities_and_equity": {"value": 375108000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_noncurrent_liabilities": {"value": 47764000.0, "unit": "USD", "label": "Other Non-current Liabilities", "order": 820}, "current_assets": {"value": 293071000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "current_liabilities": {"value": 86492000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "wages": {"value": 15624000.0, "unit": "USD", "label": "Wages", "order": 730}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "accounts_payable": {"value": 6834000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity": {"value": -373218000.0, "unit": "USD", "label": "Equity", "order": 1400}}}}, {"start_date": "2020-10-01", "end_date": "2020-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2020", "cik": "0001583107", "sic": "2834", "tickers": ["TBPH"], "company_name": "Theravance Biopharma, Inc.", "financials": {"balance_sheet": {"current_liabilities": {"value": 123571000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_liabilities": {"value": 649237000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_noncurrent_liabilities": {"value": 30067000.0, "unit": "USD", "label": "Other Non-current Liabilities", "order": 820}, "accounts_payable": {"value": 6775000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "fixed_assets": {"value": 16422000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "assets": {"value": 469057000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities": {"value": 772808000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "wages": {"value": 35238000.0, "unit": "USD", "label": "Wages", "order": 730}, "equity_attributable_to_parent": {"value": -303751000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_assets": {"value": 393341000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_assets": {"value": 75716000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "long_term_debt": {"value": 619170000.0, "unit": "USD", "label": "Long-term Debt", "order": 810}, "other_noncurrent_assets": {"value": 59294000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "liabilities_and_equity": {"value": 469057000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_current_liabilities": {"value": 81558000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity": {"value": -303751000.0, "unit": "USD", "label": "Equity", "order": 1400}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -58434000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -58434000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "income_statement": {"diluted_average_shares": {"value": 464000, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss": {"value": -58434000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_expenses": {"value": 95220000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "research_and_development": {"value": 65165000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "operating_income_loss": {"value": -76490000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "basic_average_shares": {"value": 447000, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "income_loss_from_continuing_operations_before_tax": {"value": 18730000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "income_loss_from_continuing_operations_after_tax": {"value": -58434000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_parent": {"value": -58434000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_before_equity_method_investments": {"value": -87372000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "selling_general_and_administrative_expenses": {"value": 30055000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -58434000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_equity_method_investments": {"value": 20139000.0, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "income_tax_expense_benefit": {"value": -8799000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "costs_and_expenses": {"value": 95220000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "interest_expense_operating": {"value": 11680000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "revenues": {"value": 18730000.0, "unit": "USD", "label": "Revenues", "order": 100}}, "cash_flow_statement": {"net_cash_flow_continuing": {"value": -11814000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": 52368000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -64925000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -64925000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": -11814000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": 743000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": 52368000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 743000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}}}}]